Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The nucleotide switch of tubulin and microtubule assembly: A polymerization-driven structural change
Tailored for humans, it achieved the FDAs approval list in 2017 for the treatment of type 2 diabetes
Liraglutide (Victoza): A Human GLP-1 Analog for Once-Daily Use Liraglutide is a modified human GLP-1 analog essentially, it has the same amino acid sequence as human GLP-1 (7-37) except for two modifications: an arginine substitution at one position and a C-16 fatty acid chain attached via a spacer to Lysine at position 26 ( [111] )
These medications mimic the incretin hormones that the body usually produces to stimulate insulin secretion in response to meals, thereby helping regulate blood sugar levels
As expected, the market for these drugs is exploding
R., Cho, H
US$ 27.29
US$ 24.30
US$ 25.29
US$ 20.54
